Skylands Capital, LLC Volitionrx LTD Transaction History
Skylands Capital, LLC
- $660 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
30Shares Held
17.3MCall Options Held
37KPut Options Held
100-
Armistice Capital, LLC New York, NY8.48MShares$4.75 Million0.07% of portfolio
-
Lagoda Investment Management, L.P. New York, NY7.58MShares$4.24 Million2.46% of portfolio
-
Geode Capital Management, LLC Boston, MA744KShares$416,5520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$356,5330.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$289,0000.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $32.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...